Therapeutic Implications of TGFβ in Cancer Treatment: A Systematic Review

Area of Science:

• Oncology
• Molecular Biology
• Immunology

Background:

• Transforming growth factor beta (TGFβ) is a critical cytokine involved in numerous biological processes.
• Dysregulation of TGFβ signaling is implicated in various pathologies, notably cancer.
• The complex, context-dependent role of TGFβ in cancer (suppressor vs. promoter) complicates therapeutic development.

Purpose of the Study:

• To systematically review current therapeutic strategies targeting TGFβ signaling for cancer treatment.
• To provide insights into approaches regulating TGFβ synthesis, activation, and signaling pathways.
• To discuss the efficacy and potential complications of these emerging cancer therapies.

Main Methods:

• Systematic literature review of therapeutic strategies targeting TGFβ in cancer.
• Analysis of approaches including antisense oligonucleotides, receptor interaction blockers, and signaling cascade inhibitors.
• Evaluation of the effectiveness and safety profiles of discussed therapeutic interventions.

Main Results:

• Multiple therapeutic avenues targeting TGFβ are under investigation for cancer treatment.
• Strategies include inhibiting TGFβ synthesis (e.g., antisense oligonucleotides) and blocking its receptor interactions.
• Inhibitors of downstream TGFβ signaling components are also explored.

Conclusions:

• Targeting TGFβ presents a promising but challenging strategy in cancer therapy due to its dual role.
• A range of therapeutic approaches are being researched, each with potential benefits and drawbacks.
• Further research is needed to develop safe and effective TGFβ-targeted cancer treatments.